Giuseppe Cosentino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Giuseppe Cosentino has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
Cristina Tassorelli
Department of Brain and Behavioral Sciences University of Pavia Pavia Italy
9 shared publicationsEnrico Alfonsi
9 shared publications- Massimiliano Todisco
Translational Neurophysiology Research Unit, IRCCS Mondino Foundation, Pavia, Italy
8 shared publications - Cristina Tassorelli
University of Pavia
7 shared publications Massimiliano Todisco
Translational Neurophysiology Research Section, IRCCS Mondino Foundation, Pavia, Italy
7 shared publications- Filippo Brighina
Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy
5 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (8) , e70739
Refining Electrophysiological Criteria in CIDP and MMN : Toward a Unified Definition of Motor Conduction Block and Proximal Temporal Dispersion
Background: The definition of motor conduction block (CB) and proximal temporal dispersion (TD) for the diagnosis of CIDP and MMN remains debated, particularly regarding whether CB should be based on amplitude or area reduction, and whether proximal TD is best assessed using negative peak or total CMAP duration. Methods: Nerve conduction waveforms from 106 CIDP, 87 MMN, and 234 controls were analyzed. Motor CB was defined by ≥ 30%, ≥ 40%, or ≥ 50% amplitude or area reduction. Proximal TD was defined as a ≥ 30% increase in negative peak duration, total CMAP duration, or either criterion. Sensitivity, specificity, and inter‐rater reliability were analyzed. Results: Across both CIDP and MMN, a ≥ 30% reduction in CMAP amplitude showed diagnostic performance comparable to area‐based CB definitions and outperformed higher cutoff values. Requiring CB in multiple nerves increased specificity but reduced sensitivity. For proximal TD, negative peak duration was the most robust single parameter. Total CMAP duration identified additional abnormalities and, when combined with negative peak duration, improved diagnostic sensitivity in both disorders while maintaining high specificity. Total CMAP duration demonstrated good inter‐rater agreement at the patient level. CMAP morphology showed substantial overlap between CIDP and MMN and limited discriminatory value. Conclusions: A ≥ 30% reduction in CMAP amplitude can be used as a universal definition of motor CB in both CIDP and MMN, providing diagnostic performance comparable to area‐based criteria with greater simplicity. In addition, proximal TD assessed using total CMAP duration may represent a complementary electrophysiological criterion in both disorders.
- 18 August 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (8) , e70739
Open AccessRefining Electrophysiological Criteria in CIDP and MMN : Toward a Unified Definition of Motor Conduction Block and Proximal Temporal Dispersion
Background: The definition of motor conduction block (CB) and proximal temporal dispersion (TD) for the diagnosis of CIDP and MMN remains debated, particularly regarding whether CB should be based on amplitude or area reduction, and whether proximal TD is best assessed using negative peak or total CMAP duration. Methods: Nerve conduction waveforms from 106 CIDP, 87 MMN, and 234 controls were analyzed. Motor CB was defined by ≥ 30%, ≥ 40%, or ≥ 50% amplitude or area reduction. Proximal TD was defined as a ≥ 30% increase in negative peak duration, total CMAP duration, or either criterion. Sensitivity, specificity, and inter‐rater reliability were analyzed. Results: Across both CIDP and MMN, a ≥ 30% reduction in CMAP amplitude showed diagnostic performance comparable to area‐based CB definitions and outperformed higher cutoff values. Requiring CB in multiple nerves increased specificity but reduced sensitivity. For proximal TD, negative peak duration was the most robust single parameter. Total CMAP duration identified additional abnormalities and, when combined with negative peak duration, improved diagnostic sensitivity in both disorders while maintaining high specificity. Total CMAP duration demonstrated good inter‐rater agreement at the patient level. CMAP morphology showed substantial overlap between CIDP and MMN and limited discriminatory value. Conclusions: A ≥ 30% reduction in CMAP amplitude can be used as a universal definition of motor CB in both CIDP and MMN, providing diagnostic performance comparable to area‐based criteria with greater simplicity. In addition, proximal TD assessed using total CMAP duration may represent a complementary electrophysiological criterion in both disorders.
- Open Access
- 23 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Association between the Eating Assessment Tool-10 and electrokinesiographic study of swallowing in dementia
- 23 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessAssociation between the Eating Assessment Tool-10 and electrokinesiographic study of swallowing in dementia
- Open Access
- 1 July 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (7) , e70686
Intensive Rehabilitation With Adjunctive Bilateral Anodal tDCS in Post‐Stroke Dysphagia: A Multicenter Randomized Controlled Trial
Background: Oropharyngeal dysphagia is a common and disabling consequence of stroke. Transcranial direct current stimulation (tDCS) has shown potential in promoting swallowing recovery, although evidence remains limited. Objective: To determine whether bilateral anodal tDCS combined with intensive speech‐language therapy (SLT) improves swallowing outcomes compared with sham stimulation in patients with post‐stroke dysphagia. Exploratory analyses examined the influence of treatment phase, sex, lesion site, and baseline severity. Methods: This multicenter, randomized, double‐blind, sham‐controlled trial enrolled patients with supratentorial or infratentorial ischemic stroke and oropharyngeal dysphagia. Participants received either bilateral anodal tDCS or sham stimulation (1.5 mA, 20 min/day, 5 days/week for 2 weeks) combined with intensive SLT over 6 weeks. Swallowing outcomes were assessed at baseline, 2 weeks, and 6 weeks using the Dysphagia Outcome and Severity Scale (DOSS, primary outcome), Penetration–Aspiration Scale (PAS), Mann Assessment of Swallowing Ability (MASA), and Swallowing Quality of Life questionnaire (SWAL‐QoL). Results: Forty‐six patients (24 active, 22 sham) completed the protocol. Both groups showed significant improvement across all outcomes ( p < 0.001), with no significant difference between active and sham stimulation. The DOSS was the most sensitive measure, showing sustained improvement over time. Exploratory analyses indicated greater MASA gains with active tDCS in infratentorial strokes ( p = 0.04). Correlation analyses showed that greater baseline dysphagia severity was associated with larger functional gains. Conclusions: Intensive SLT was associated with meaningful recovery in post‐stroke dysphagia, regardless of stimulation condition. Exploratory findings suggest that bilateral tDCS may confer additional benefit in selected lesion subgroups.
- 1 July 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (7) , e70686
Open AccessIntensive Rehabilitation With Adjunctive Bilateral Anodal tDCS in Post‐Stroke Dysphagia: A Multicenter Randomized Controlled Trial
Background: Oropharyngeal dysphagia is a common and disabling consequence of stroke. Transcranial direct current stimulation (tDCS) has shown potential in promoting swallowing recovery, although evidence remains limited. Objective: To determine whether bilateral anodal tDCS combined with intensive speech‐language therapy (SLT) improves swallowing outcomes compared with sham stimulation in patients with post‐stroke dysphagia. Exploratory analyses examined the influence of treatment phase, sex, lesion site, and baseline severity. Methods: This multicenter, randomized, double‐blind, sham‐controlled trial enrolled patients with supratentorial or infratentorial ischemic stroke and oropharyngeal dysphagia. Participants received either bilateral anodal tDCS or sham stimulation (1.5 mA, 20 min/day, 5 days/week for 2 weeks) combined with intensive SLT over 6 weeks. Swallowing outcomes were assessed at baseline, 2 weeks, and 6 weeks using the Dysphagia Outcome and Severity Scale (DOSS, primary outcome), Penetration–Aspiration Scale (PAS), Mann Assessment of Swallowing Ability (MASA), and Swallowing Quality of Life questionnaire (SWAL‐QoL). Results: Forty‐six patients (24 active, 22 sham) completed the protocol. Both groups showed significant improvement across all outcomes ( p < 0.001), with no significant difference between active and sham stimulation. The DOSS was the most sensitive measure, showing sustained improvement over time. Exploratory analyses indicated greater MASA gains with active tDCS in infratentorial strokes ( p = 0.04). Correlation analyses showed that greater baseline dysphagia severity was associated with larger functional gains. Conclusions: Intensive SLT was associated with meaningful recovery in post‐stroke dysphagia, regardless of stimulation condition. Exploratory findings suggest that bilateral tDCS may confer additional benefit in selected lesion subgroups.
- Open Access
- 10 June 2026
- Published by Elsevier in Clinical Neurophysiology
- Vol. 190, 2111974
Distinct patterns of small-fiber dysfunction in anti-myelin-associated glycoprotein-positive and negative paraproteinemic neuropathies
- 10 June 2026
- Published by Elsevier in Clinical Neurophysiology
- Vol. 190, 2111974
Open AccessDistinct patterns of small-fiber dysfunction in anti-myelin-associated glycoprotein-positive and negative paraproteinemic neuropathies
- Open Access
- 30 April 2026
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 133 (9) , 2417-2428
Abnormal swallowing–breathing coordination is an electrokinesiographic feature of dysphagia in multiple system atrophy: a comparative study with Parkinson’s disease
Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by autonomic failure and motor impairment, with dysphagia emerging early and representing a key feature for differential diagnosis from Parkinson’s disease (PD). Safe and efficient swallowing relies on precise coordination between oropharyngeal events and breathing, yet this interaction has not been systematically investigated in MSA. To quantify the temporal relationships between oropharyngeal phases and breathing during water and jelly swallows, we retrospectively analyzed the electrokinesiographic study of swallowing (EKSS) from 38 patients with the parkinsonian variant of MSA (MSA-P), 16 patients with the cerebellar variant of MSA (MSA-C), 21 patients with PD, and 15 healthy controls. MSA patients exhibited widespread oropharyngeal dysfunction across both bolus consistencies, with MSA-C showing the most severe abnormalities. Both MSA phenotypes indeed displayed multiple EKSS alterations consistent with disrupted swallowing–breathing coordination, including paradoxical sequencing and prolonged inter-events intervals. The MSA-C group showed additional impairment in the control of the upper esophageal sphincter. In contrast, PD patients had milder EKSS abnormalities, predominantly involving oral phase parameters. The post-swallowing inspiration index reliably discriminated MSA from PD across all bolus types, being significantly higher in MSA patients and indicating more pronounced swallowing–breathing desynchronization. These findings provide a detailed neurophysiological characterization of oropharyngeal swallowing in MSA and PD, highlighting disease- and phenotype-specific patterns: predominant impairment of the pharyngeal phase and its coordination with breathing in MSA, particularly in MSA-C, and mainly oral phase involvement in PD.
- 30 April 2026
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 133 (9) , 2417-2428
Open AccessAbnormal swallowing–breathing coordination is an electrokinesiographic feature of dysphagia in multiple system atrophy: a comparative study with Parkinson’s disease
Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by autonomic failure and motor impairment, with dysphagia emerging early and representing a key feature for differential diagnosis from Parkinson’s disease (PD). Safe and efficient swallowing relies on precise coordination between oropharyngeal events and breathing, yet this interaction has not been systematically investigated in MSA. To quantify the temporal relationships between oropharyngeal phases and breathing during water and jelly swallows, we retrospectively analyzed the electrokinesiographic study of swallowing (EKSS) from 38 patients with the parkinsonian variant of MSA (MSA-P), 16 patients with the cerebellar variant of MSA (MSA-C), 21 patients with PD, and 15 healthy controls. MSA patients exhibited widespread oropharyngeal dysfunction across both bolus consistencies, with MSA-C showing the most severe abnormalities. Both MSA phenotypes indeed displayed multiple EKSS alterations consistent with disrupted swallowing–breathing coordination, including paradoxical sequencing and prolonged inter-events intervals. The MSA-C group showed additional impairment in the control of the upper esophageal sphincter. In contrast, PD patients had milder EKSS abnormalities, predominantly involving oral phase parameters. The post-swallowing inspiration index reliably discriminated MSA from PD across all bolus types, being significantly higher in MSA patients and indicating more pronounced swallowing–breathing desynchronization. These findings provide a detailed neurophysiological characterization of oropharyngeal swallowing in MSA and PD, highlighting disease- and phenotype-specific patterns: predominant impairment of the pharyngeal phase and its coordination with breathing in MSA, particularly in MSA-C, and mainly oral phase involvement in PD.
- 16 January 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (7) , 1744-1747
Dropped Head Syndrome Unmasking Myotonic Dystrophy Type 1 in a Patient with Parkinson's Disease: A Case Report and a Case‐Based Review
- 16 January 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (7) , 1744-1747
Dropped Head Syndrome Unmasking Myotonic Dystrophy Type 1 in a Patient with Parkinson's Disease: A Case Report and a Case‐Based Review
- Open Access
Unilateral EMG-Guided Botulinum Toxin for Retrograde Cricopharyngeus Dysfunction: A Prospective Clinical and Neurophysiological Study
Retrograde cricopharyngeus dysfunction (R-CPD) is a recently recognized condition characterized by the inability to burp, typically accompanied by gurgling noises, bloating, and flatulence. Percutaneous botulinum neurotoxin (BoNT) injection into the cricopharyngeus muscle is a minimally invasive treatment with promising effects, although current evidence remains limited. In this prospective, open-label study, we evaluated the clinical effects of increasing doses (10 to 30 U) of EMG-guided unilateral BoNT injection in 67 patients with R-CPD. Symptom severity and quality of life were assessed at baseline and at 1 and 4 months post-treatment. The electromyographic (EMG) parameters of the cricopharyngeus were recorded to explore their association with symptom burden and treatment response. At a 1-month follow-up, 55.2% of patients were classified as responders (satisfaction score ≥ 6/10), with a higher rate (64.4%) observed at higher doses, particularly in female patients. Both symptom severity and quality of life improved significantly at 1 month and were sustained at 4 months. Higher cricopharyngeus EMG activity was associated with more severe symptoms and lesser treatment responses. Unilateral EMG-guided BoNT injection is a safe and effective treatment for R-CPD. Further studies should explore the potential role of electromyography in clarifying the pathophysiological aspects of R-CPD and guiding treatment.
Open AccessUnilateral EMG-Guided Botulinum Toxin for Retrograde Cricopharyngeus Dysfunction: A Prospective Clinical and Neurophysiological Study
Retrograde cricopharyngeus dysfunction (R-CPD) is a recently recognized condition characterized by the inability to burp, typically accompanied by gurgling noises, bloating, and flatulence. Percutaneous botulinum neurotoxin (BoNT) injection into the cricopharyngeus muscle is a minimally invasive treatment with promising effects, although current evidence remains limited. In this prospective, open-label study, we evaluated the clinical effects of increasing doses (10 to 30 U) of EMG-guided unilateral BoNT injection in 67 patients with R-CPD. Symptom severity and quality of life were assessed at baseline and at 1 and 4 months post-treatment. The electromyographic (EMG) parameters of the cricopharyngeus were recorded to explore their association with symptom burden and treatment response. At a 1-month follow-up, 55.2% of patients were classified as responders (satisfaction score ≥ 6/10), with a higher rate (64.4%) observed at higher doses, particularly in female patients. Both symptom severity and quality of life improved significantly at 1 month and were sustained at 4 months. Higher cricopharyngeus EMG activity was associated with more severe symptoms and lesser treatment responses. Unilateral EMG-guided BoNT injection is a safe and effective treatment for R-CPD. Further studies should explore the potential role of electromyography in clarifying the pathophysiological aspects of R-CPD and guiding treatment.
- 23 March 2025
- Published by Springer Nature
- p. 31-100
18 Diagnosis and Differential Diagnosis of Acquired Motor Speech Disorders (Dysarthria, Dyspraxia)
- 23 March 2025
- Published by Springer Nature
- p. 31-100
18 Diagnosis and Differential Diagnosis of Acquired Motor Speech Disorders (Dysarthria, Dyspraxia)
- Open Access
- 10 March 2025
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 26 (1) , 1-17
Offset analgesia as a marker of dysfunctional pain modulation in episodic and chronic migraine
The offset analgesia phenomenon refers to the disproportionately large decrease in the perceived pain following a slight decrease in intensity of a noxious heat stimulus. It is considered an expression of the activation of the endogenous pain-modulation system. The main aim of this study was to examine pain processing using the offset analgesia paradigm in subjects with interictal episodic migraine compared to those with non-ictal chronic migraine. Additionally, as secondary outcome measures, we aimed to: (1) explore fluctuations in the endogenous pain modulation system throughout the migraine cycle by including small subgroups of episodic migraine patients in different migraine phases, and (2) compare different subgroups of non-ictal chronic migraine patients with or without medication overuse headache (MOH). A total of 68 subjects with episodic migraine (different subjects were evaluated during the interictal, preictal, ictal, or postictal phase), 34 with non-ictal chronic migraine with or without MOH, and 30 healthy controls were enrolled. Participants underwent six trials involving constant temperature and stimulus offset applied to the forehead, with pain responses measured using a continuous analogue-to-digital converter of VAS. The offset analgesia phenomenon was recorded predominantly during the postictal phase among the population of episodic migraine patients, as well as in healthy subjects. Offset analgesia was generally absent in interictal episodic migraine subjects and in subjects with chronic migraine with MOH, though some individual variability was observed. A paradoxical increase in pain facilitation was observed in most preictal and ictal episodic migraine subjects, as well as in chronic migraine subjects without MOH. The severity of offset analgesia impairment correlated with scores on the Allodynia Symptom Checklist and the Numeric Pain Rating Scale, which assessed average headache intensity during untreated migraine attacks. Episodic and chronic migraine patients exhibit disrupted top-down pain modulation pathways, with more significant alterations in chronic migraine without MOH. Additionally, we provide preliminary evidence that cyclical changes in the endogenous pain modulation system could contribute to migraine recurrence in episodic migraine sufferers. However, given the small subgroups of interictal patients evaluated in different migraine phases and the cross-sectional study design, these findings should be interpreted with caution and confirmed by future longitudinal studies with larger sample sizes.
- 10 March 2025
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 26 (1) , 1-17
Open AccessOffset analgesia as a marker of dysfunctional pain modulation in episodic and chronic migraine
The offset analgesia phenomenon refers to the disproportionately large decrease in the perceived pain following a slight decrease in intensity of a noxious heat stimulus. It is considered an expression of the activation of the endogenous pain-modulation system. The main aim of this study was to examine pain processing using the offset analgesia paradigm in subjects with interictal episodic migraine compared to those with non-ictal chronic migraine. Additionally, as secondary outcome measures, we aimed to: (1) explore fluctuations in the endogenous pain modulation system throughout the migraine cycle by including small subgroups of episodic migraine patients in different migraine phases, and (2) compare different subgroups of non-ictal chronic migraine patients with or without medication overuse headache (MOH). A total of 68 subjects with episodic migraine (different subjects were evaluated during the interictal, preictal, ictal, or postictal phase), 34 with non-ictal chronic migraine with or without MOH, and 30 healthy controls were enrolled. Participants underwent six trials involving constant temperature and stimulus offset applied to the forehead, with pain responses measured using a continuous analogue-to-digital converter of VAS. The offset analgesia phenomenon was recorded predominantly during the postictal phase among the population of episodic migraine patients, as well as in healthy subjects. Offset analgesia was generally absent in interictal episodic migraine subjects and in subjects with chronic migraine with MOH, though some individual variability was observed. A paradoxical increase in pain facilitation was observed in most preictal and ictal episodic migraine subjects, as well as in chronic migraine subjects without MOH. The severity of offset analgesia impairment correlated with scores on the Allodynia Symptom Checklist and the Numeric Pain Rating Scale, which assessed average headache intensity during untreated migraine attacks. Episodic and chronic migraine patients exhibit disrupted top-down pain modulation pathways, with more significant alterations in chronic migraine without MOH. Additionally, we provide preliminary evidence that cyclical changes in the endogenous pain modulation system could contribute to migraine recurrence in episodic migraine sufferers. However, given the small subgroups of interictal patients evaluated in different migraine phases and the cross-sectional study design, these findings should be interpreted with caution and confirmed by future longitudinal studies with larger sample sizes.
- Open Access
Effects of Repetitive Transcranial Magnetic Stimulation Applied over the Primary Motor Cortex on the Offset Analgesia Phenomenon
In this study, we investigate the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied over the left upper limb primary motor cortex (M1) on the offset analgesia (OA) phenomenon, a measure of endogenous pain modulation. In particular, we aim to determine whether rTMS influences OA differently in the forearm region, corresponding to the stimulated cortical area, compared to the trigeminal region. Twenty-two healthy volunteers underwent three experimental sessions: a baseline session without stimulation, an active rTMS session, and a sham rTMS session. Quantitative sensory testing (QST) paradigms, including warm and cold detection thresholds, heat pain threshold corresponding to a visual analogue scale (VAS) score of approximately 50–60 out of 100 (Pain50–60), and constant and offset trials, were assessed in both the forearm and trigeminal regions. The results revealed that active rTMS significantly enhanced the OA phenomenon in the forearm during the late phase, while no significant effects were observed in the trigeminal region. These findings suggest that rTMS may modulate central pain mechanisms in a body region-specific manner, potentially linked to the somatotopic organization of M1. This study points to possible mechanisms of action of rTMS for pain relief, highlighting the importance of region-specific effects in chronic pain treatment. Further research is needed to investigate the underlying mechanisms and clinical applicability of rTMS in patients with chronic pain conditions, especially when OA is compromised.
Open AccessEffects of Repetitive Transcranial Magnetic Stimulation Applied over the Primary Motor Cortex on the Offset Analgesia Phenomenon
In this study, we investigate the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied over the left upper limb primary motor cortex (M1) on the offset analgesia (OA) phenomenon, a measure of endogenous pain modulation. In particular, we aim to determine whether rTMS influences OA differently in the forearm region, corresponding to the stimulated cortical area, compared to the trigeminal region. Twenty-two healthy volunteers underwent three experimental sessions: a baseline session without stimulation, an active rTMS session, and a sham rTMS session. Quantitative sensory testing (QST) paradigms, including warm and cold detection thresholds, heat pain threshold corresponding to a visual analogue scale (VAS) score of approximately 50–60 out of 100 (Pain50–60), and constant and offset trials, were assessed in both the forearm and trigeminal regions. The results revealed that active rTMS significantly enhanced the OA phenomenon in the forearm during the late phase, while no significant effects were observed in the trigeminal region. These findings suggest that rTMS may modulate central pain mechanisms in a body region-specific manner, potentially linked to the somatotopic organization of M1. This study points to possible mechanisms of action of rTMS for pain relief, highlighting the importance of region-specific effects in chronic pain treatment. Further research is needed to investigate the underlying mechanisms and clinical applicability of rTMS in patients with chronic pain conditions, especially when OA is compromised.